S Iho
Overview
Explore the profile of S Iho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsugita K, Hirose M, Murata E, Iho S
Eur J Anaesthesiol
. 2008 Nov;
25(12):1032-3.
PMID: 18990260
No abstract available.
2.
Yamamoto S, Yamamoto T, Iho S, Tokunaga T
Springer Semin Immunopathol
. 2000 Aug;
22(1-2):35-43.
PMID: 10944798
No abstract available.
3.
Fujieda S, Iho S, Kimura Y, Yamamoto H, Igawa H, Saito H
Am J Respir Crit Care Med
. 2000 Jul;
162(1):232-9.
PMID: 10903247
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs have the capacity to stimulate T-helper (Th)1-type responses in mice. Th1 cytokines are known to act as downregulators of IgE production. In this...
4.
Fujieda S, Iho S, Kimura Y, SUNAGA H, Igawa H, Sugimoto C, et al.
Am J Respir Crit Care Med
. 1999 Dec;
160(6):2056-61.
PMID: 10588628
A DNA fraction purified from Mycobacterium bovis bacillus Calmette-Guérin (BCG) and designated MY-1 induced interferon (IFN)-gamma production by human peripheral blood mononuclear cells (PBMC). IFN-gamma is well known as a...
5.
Iho S, Yamamoto T, Takahashi T, Yamamoto S
J Immunol
. 1999 Sep;
163(7):3642-52.
PMID: 10490958
Previous studies have shown that the action of bacterial or synthetic oligodeoxynucleotide (oligo-DNA) on mouse NK cells to produce IFN-gamma is mediated mostly by monocytes/macrophages activated by olig-DNA. However, its...
6.
Sasaki Y, Takahashi T, Miyazaki H, Matsumoto A, Kato T, Nakamura K, et al.
Blood
. 1999 Sep;
94(6):1952-60.
PMID: 10477724
Thrombocytosis is occasionally seen in patients with carcinomas and has been assumed to be attributable to interleukin-6 or granulocyte-macrophage colony-stimulating factor produced by carcinoma cells. In this study, we clarified...
7.
Takahashi T, Nakamura K, Iho S
Leuk Lymphoma
. 1997 Dec;
27(1-2):25-33.
PMID: 9373193
It is well established that 1,25(OH)2D3 induces monocyte/macrophage (Mo/Mphi) colonies when added to culture of granulocyte/macrophage progenitors. Recently, we demonstrated that one of the target cells of 1,25(OH)2D3 in Mo/Mphi...
8.
Nakamura K, Takahashi T, Sasaki Y, Tsuyuoka R, Okuno Y, Kurino M, et al.
Blood
. 1996 Apr;
87(7):2693-701.
PMID: 8639885
Although it is well established that the addition of 1,25-dihydroxyvitamin D3 (D3) to the culture of normal human granulocyte/macrophage progenitors induces monocyte/macrophage (Mo/M phi) colonies, the target cells of D3...
9.
Iho S, Shau H
Scand J Immunol
. 1994 Mar;
39(3):233-40.
PMID: 8128185
The authors demonstrated previously that a short-term treatment with IL-6 of lymphokine-activated killer (LAK) cells produces an increase in cytotoxic activity of CD56+/CD3- effector cells generated from human PBL as...
10.
Iho S, Golub S, Shau H
Scand J Immunol
. 1993 Aug;
38(2):137-41.
PMID: 8346413
TNF-alpha at 50-100 U/ml synergizes with IL-2 in enhancing LAK activity and IL-6 production in low-dose IL-2 (1-10 U/ml) culture of human PBL. High-dose TNF-alpha (> or = 200 U/ml)...